Tuberculosis is a global healthcare challenge. To work towards its elimination, partners from all over the world need to join together . This is why in 2001, the World Health Organization (WHO) established the STOP TB Partnership. Its goal is to dramatically reduce the global burden of tuberculosis by 2015 by ensuring all TB patients, including for example, those co-infected with HIV and those with drug-resistant TB, benefit from universal access to high-quality diagnosis and patient-centered treatment.
The partnership has nearly 1000 partners that are collectively transforming the fight against TB in more than 100 countries. They include international and technical organizations, government programmes, research and funding agencies, foundations, NGOs, civil society and community groups and the private sector – including Sandoz.
Patient-centered TB treatment
Novartis Foundation for Sustainable Development (NFSD) in collaboration with the National TB and Leprosy Programme of the Tanzanian Ministry of Health and Social Welfare developed the Patient-Centered TB Treatment (PCT) approach to improve access to treatment for patients in Tanzania.
Prof. Peter Donald, Emeritus professor in Pediatrics and Child Health at the Faculty of Health Sciences of the University of Stellenbosch and Tygerberg Children's Hospital, South Africa shares his views on treatment of Childhood TB management.